What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2025-05-30 compared with 2024-04-01 · 26 added, 37 removed, 34 unchanged (65% of the section changed)

MARKET FOR REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

common stock is quoted on the OTCQB tier of the OTC Markets Group, Inc.

under the symbol, “BTTC.” The OTC Market is a network

of security dealers who buy and sell stock.

The dealers are connected by a computer network that provides information on current “bids”

and “asks”, as well as volume information.

following table sets forth trading information for our common stock for the periods indicated, as quoted on the OTCQB.

These quotations

reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.

Low Trading Price

High Trading Price

Year Ended December 31, 2023

Fourth Quarter (December 31, 2023)

Third Quarter (September 30, 2023)

Second Quarter (June 30, 2023)

First Quarter (March 31, 2023)

Year Ended December 31, 2022

Fourth Quarter (December 31, 2022)

Third Quarter (September 30, 2022)

Second Quarter (June 30, 2022)

First Quarter (March 31, 2022)

of December 31, 2024 there were approximately 121 record holders of our common stock.

18 unchanged sentences

provided by Section 4(a)(2) of the Securities Act, or Regulation D or Regulation S promulgated thereunder.

December 21, 2022, the Company awarded a director as Compensation service to the Company as a director, an option to purchase 5,000,000

shares of the Company’s Common Stock at an exercise price of $0.07 per share which vest as to 20% of the award on each

December 21, beginning December 21, 2023, so long as such directors is providing services to the Company or one of its subsidiaries subject

to acceleration in the event of termination for cause.

February 13, 2023, the Company awarded an officer and director of the Company as compensation for service to the Company, an option to

purchase 5,000,000 shares of the Company’s Common Stock at an exercise price of $0.025 per share which vest 80% on date of grant

and 10% on January 1, 2024 and 10% on January 1, 2025 so long as person is providing services to the Company or one of its subsidiaries

subject to acceleration in the event of termination for cause.

purchase 35,715 shares of the Company’s Common Stock at an exercise price of $3.50 per share which vested 80% on date of grant

and 10% on January 1, 2024 and 10% on January 1, 2025.

April 3, 2023, the Company awarded a director as Compensation for service to the Company as a director, an option to purchase 35,715

shares of the Company’s Common Stock at an exercise price of $0.03 per share which vest 50% of the date of grant and 50% on April

3, 2024, so long as such director is providing services to the Company or one of its subsidiaries subject to acceleration in the event

of termination for cause.

shares of the Company’s Common Stock at an exercise price of $4.20 per share which vested 50% of the date of grant and 50% on April

April 3, 2023, the Company awarded an officer and director of the Company as compensation for services to the Company an option to purchase

5,000,000 shares of the Company’s Common Stock at an exercise price of $0.03 per share which vests 50% on date of award on April

3, 2023 and 50% on April 3, 2024, so long as person is providing services to the Company or one of its subsidiaries subject to acceleration

in the event of termination for cause.

35,715 shares of the Company’s Common Stock at an exercise price of $4.20 per share which vested 50% on date of award on April

3, 2023 and 50% on April 3, 2024.

November 27, 2023, the Company awarded a director as compensation for services to the Company as a director, 7,143 shares of restricted

1 unchanged sentence

The value of this award was $20,000.

November 27, 2023, the Company awarded an Officer and director of 500,000 shares of restricted Common Stock which vests 100% on December

31, 2023 so long as such person is providing services to the Company or one of its subsidiaries.

Company issued 1,674506 unregistered shares of its Common Stock valued at $117,455 during the year ended December 31, 2023 as payment

for services provided to the Company.

November 27, 2023, the Company awarded an Officer and director of 3,572 shares of restricted Common Stock which vested 100% on December

The value of this award was $10,000.

Company issued 11,961 unregistered shares of its Common Stock valued at 58,221 during the year ended December 31, 2023 as payment for

services provided to the Company.

April, May and June, 2023, the Company sold 80,358 unregistered shares of its Common Stock to six private investors in exchange for $225,000

3 unchanged sentences

($4.20-$5.60 per share)

the year ended December 31, 2024 the Company sold 64,337 unregistered shares of its Common Stock to eight private investors for an aggregate

of $576,000 ($7.00 - $11.20 per share)

Company issued 6,970 unregistered shares of its Common Stock valued at $79,209 during the year ended December 31, 2024 as payment for

services provided to the Company.

Company issued 14,286 of restricted securities awards valued at $120,000 ($8.40 per share) during January 2024 and recorded $30,000 as

stock compensation expense in the quarter ended March 31, 2024 as payment for services provided by two employees of the Company.

were cancelled as of December 2024 and 10,715 restricted common shares were cancelled.

Company issued 17,143 of restricted securities awards valued at $192,000 ($11.20 per share) on July 1, 2024 and recorded $72,000 as stock

compensation expense in the year ended December 31, 2024 as payment for services provided by the consultant of the Company.

The remaining

will vest quarterly through April 2026.

of the securities referred to above were issued without registration under the Securities Act of 1933, as amended (the “Securities

Act”) in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as provided in Rule 506(b) of Regulation

D promulgated thereunder.

None of the foregoing securities as well as common stock issuable upon conversion or exercise of such securities,

have been registered under the Securities Act or any other applicable laws and are deemed restricted securities, and unless so registered

may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities

Compensation Plan Information

1 unchanged sentence

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity